Clinical trials
Pulmonary Disease, Chronic Obstructive trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
99 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 10 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 8 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 10 |
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 86 |
| Unknown status | 6 |
| Recruiting | 5 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 15 |
| Boehringer Ingelheim | 12 |
| AstraZeneca | 11 |
| Norwegian University of Science and Technology | 10 |
| LHL Helse | 9 |
| Novartis Pharmaceuticals | 6 |
| Sanofi | 3 |
| Haukeland University Hospital | 2 |
| Lovisenberg Diakonale Hospital | 2 |
| St. Olavs Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 99 |
| Asthma | 5 |
| Hypoxia | 4 |
| Anxiety Disorders | 3 |
| Lung Diseases | 3 |
| Lung Diseases, Obstructive | 3 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Dyspnea | 2 |
| Nasal Obstruction | 2 |
Trials
Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.